BIOMAT Database Logo BIOMAT Database Logo

Eccentric dosage regimen for isosorbide dinitrate. 1997

E R Gonzalez, and R J Chaponis, and H E Davidson

UI MeSH Term Description Entries
D007548 Isosorbide Dinitrate A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action. Cardonit 40,Dilatrate,Iso-Bid,Isodinit,Isoket,Isoket Retard-120,Isomak R,Isordil,Isotrate,Nitrosorbide,Sorbitrate,Sorbonit,Dinitrate, Isosorbide,Iso Bid,IsoBid,Isoket Retard 120,Isoket Retard120
D009735 Nursing Homes Facilities which provide nursing supervision and limited medical care to persons who do not require hospitalization. Homes, Nursing,Nursing Home
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D006707 Homes for the Aged Geriatric long-term care facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required. Old Age Homes,Residential Aged Care Facility,Senior Housing,Home, Old Age,Homes, Old Age,Housing, Senior,Old Age Home
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

E R Gonzalez, and R J Chaponis, and H E Davidson
Eccentric dosage regimen for isosorbide dinitrate.
January 1997, American family physician,
E R Gonzalez, and R J Chaponis, and H E Davidson
Eccentric dosage regimen for isosorbide dinitrate.
January 1997, American family physician,
E R Gonzalez, and R J Chaponis, and H E Davidson
High-dosage isosorbide dinitrate therapy for angina.
March 1983, Canadian Medical Association journal,
E R Gonzalez, and R J Chaponis, and H E Davidson
Isosorbide dinitrate.
January 1983, Minnesota medicine,
E R Gonzalez, and R J Chaponis, and H E Davidson
Pharmacokinetics of isosorbide dinitrate, isosorbide-2-nitrate and isosorbide-5-nitrate in renal insufficiency after repeated oral dosage.
March 1989, Klinische Wochenschrift,
E R Gonzalez, and R J Chaponis, and H E Davidson
Oral isosorbide dinitrate for angina.
October 1979, The Medical letter on drugs and therapeutics,
E R Gonzalez, and R J Chaponis, and H E Davidson
Isosorbide dinitrate pharmacokinetics.
January 1982, Arzneimittel-Forschung,
E R Gonzalez, and R J Chaponis, and H E Davidson
Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
November 1994, The Canadian journal of cardiology,
E R Gonzalez, and R J Chaponis, and H E Davidson
Isosorbide and isorbide dinitrate.
March 1980, American journal of ophthalmology,
E R Gonzalez, and R J Chaponis, and H E Davidson
Isosorbide dinitrate in angina.
December 1971, Circulation,
Copied contents to your clipboard!